Investors
Partner With Us
At BioArk Technologies, we are building the future of genetic medicine for researchers across therapeutic areas.
We are a privately held biotechnology and biopharmaceutical Contract Research Organization (CRO), specializing in advanced gene editing and gene delivery solutions.
We welcome conversations with investors who share our vision and want to be part of accelerating innovation in life sciences and genetic therapies.
Why Invest in BioArk Technologies?
- Growing Demand: Increasing global need for genetic therapies, cell and gene therapy platforms, and molecular research tools.
- Proprietary Technologies: Innovative transfection reagents, DNA/RNA engineering methods, and custom service platforms that differentiate us in the market.
- Strategic Partnerships: Collaborations across biotech startups, academic institutions, and pharmaceutical companies.
- Focused Growth Strategy: Expanding our R&D capabilities, service portfolio, and global reach.
Our Investment Philosophy
Although we are a privately held company, we are open to exploring strategic partnerships and investment opportunities that align with our mission and values.
We seek partners who are committed to advancing breakthrough science, fostering innovation, and driving sustainable growth.
Get in Touch
If you are interested in learning more about investment opportunities with BioArk Technologies, please contact us:
Investor Relations
Email: [email protected]
All inquiries will be handled with strict confidentiality.
